Article thumbnail

Experimental Human Cell and Tissue Models of Pemphigus

By Gerda van der Wier, Hendri H. Pas and Marcel F. Jonkman

Abstract

Pemphigus is a chronic mucocutaneous autoimmune bullous disease that is characterized by loss of cell-cell contact in skin and/or mucous membranes. Past research has successfully identified desmosomes as immunological targets and has demonstrated that acantholysis is initiated through direct binding of IgG. The exact mechanisms of acantholysis, however, are still missing. Experimental model systems have contributed considerably to today's knowledge and are still a favourite tool of research. In this paper we will describe to what extent human cell and tissue models represent the in vivo situation, for example, organ cultures of human skin, keratinocyte cultures, and human skin grafted on mice and, furthermore, how suitable they are to study the pathogenesis of pemphigus. Organ cultures closely mimic the architecture of the epidermis but are less suitable to answer posed biochemical questions. Cultured keratinocyte monolayers are convenient in this respect, but their desmosomal make-up in terms of adhesion molecules does not exactly reflect the in vivo situation. Reconstituted skin is a relatively new model that approaches organ culture. In models of human skin grafted on mice, acantholysis can be studied in actual human skin but now with all the advantages of an animal model

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2877615
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A novel explanation for acantholysis in pemphigus vulgaris: the basal cell shrinkage hypothesis,”
  2. (1977). An organ culture model for the study of pemphigus acantholysis,”
  3. (1980). and keratin filaments by indirect immunofluorescence in cultured human epidermal cells,”
  4. (2007). Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity,”
  5. (2001). Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in humanskingraftedontoSCIDmice,”TheJournalofPathology,
  6. (2009). Apoptosis in pemphigus,”
  7. (2009). Apoptosis is not required for acantholysis in pemphigus vulgaris,”
  8. (1979). Appearance of “pemphigus acantholysis factor” in human skin cultured with pemphigus antibody,”
  9. (2007). Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus,”
  10. (1984). Calciuminduced reorganization of desmosomal components in cultured human keratinocytes,”
  11. (2008). Cleavage of desmoglein 3 can explain its depletion from keratinocytes in pemphigus vulgaris,”
  12. (1964). Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining,”
  13. (2009). Desmocollin 3-mediated binding is crucial for keratinocyte cohesion andisimpairedinpemphigus,”JournalofBiologicalChemistry,
  14. (2006). Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies,”
  15. (2007). Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens,”
  16. (2005). Desmosome signaling: inhibition of p38MAPK prevents pemphigus vulgaris IgGinduced cytoskeleton reorganization,”
  17. (1995). Differences in the expression of pemphigus antigens during epidermal differentiation,”
  18. (1993). Dynamic expression of pemphigus and desmosomal antigens by cultured keratinocytes,”
  19. (1987). E.Tinois,M.Faure,andP.Chatelain,“Growthanddifferentiation of human keratinocytes on extracellular matrix,”
  20. (1984). E.W.B.JeffesIII,R.P.Kaplan,andA.R.Ahmed,“Acantholysis produced in vitro with pemphigus serum: hydrocortisone inhibitsacantholysis,whiledapsoneand6-mercaptopurinedo not inhibit acantholysis,”
  21. (1978). Epidermal acantholysis induced in vitro by pemphigus autoantibody. An ultrastructural study,”
  22. (2004). Espa˜ n a ,I .S ´
  23. Experimental acantholysis by complement-fixing intercellular antibodies,”
  24. (1988). Experimental suprabasal bulla formation in organ cultured human skin with low calcium medium,”
  25. (1999). Explanations for the clinical and microscopiclocalization oflesionsinpemphigusfoliaceus and vulgaris,”
  26. (2003). Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8,”
  27. (1986). Human epidermis reconstructed by culture: is it “normal”?”
  28. (1994). Identification of the ubiquitoushumandesmoglein,Dsg2,andtheexpressioncatalogue of the desmoglein subfamily of desmosomal cadherins,”
  29. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause,”
  30. (2005). In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris,”
  31. (1989). In vitro pemphigus vulgaris model using organotypic cultures of human epidermal keratinocytes,”
  32. (2006). Inhibition of Rho A activity causes pemphigus skin blistering,” J o u r n a lo fC e l lB i o l o g y ,
  33. (1976). J.R.SchiltzandB.Michel,“Productionofepidermalacantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum,” J o u r n a lo fI n v e s t i g a t i v eD e r m a t o l o g y ,
  34. (2009). Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies,”
  35. (2005). M.Frusic-Zlotkin,R.Pergamentz,B.Michel,etal.,“Theinteraction of pemphigus autoimmunoglobulins with epidermal cells: activation of the Fas apoptotic pathway and the use of caspase activity for pathogenicity testsof pemphigus patients,”
  36. (1983). Methylprednisolone inhibits pemphigus acantholysis in skin cultures,”
  37. (2007). Modeling normal and pathological processes through skin tissue engineering,”
  38. (2002). Organotypic keratinocyte coculture using normal human serum: an immunomorphological study at light and electron microscopic levels,”
  39. (2008). Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation?”
  40. (2008). p120-catenin is a novel desmoglein 3 interacting partner: identification of the p120-catenin association site of desmoglein 3,”
  41. Pemphigoid, pemphigus and Pr antigens in adult human keratinocytes grown in nonviable substrates,”
  42. (1980). Pemphigus acantholysis: a unique immunological injury,”
  43. (1978). Pemphigus antibody interactionwithhumanepidermalcellsinculture.Aproposed mechanism for pemphigus acantholysis,”
  44. (2005). Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction,”
  45. (2007). Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3,”
  46. (2004). Pemphigus serum and captopril induce heat shock protein 70 and inducible nitric oxide synthase overexpression, triggering apoptosis in human keratinocytes,”
  47. (2006). Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin,”
  48. (2009). Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor,”AmericanJournal of Pathology,
  49. (2008). Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction,”
  50. (2008). Pemphigus vulgaris IgGinduced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism,”
  51. (1999). Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X100 soluble pools, leading to the formation of Dsg3- depleted desmosomes in a human squamous carcinoma cell line, DJM1c e l l s ,
  52. (2009). Peptides targeting the desmoglein 3 adhesive interface prevent autoantibodyinduced acantholysis in pemphigus,”
  53. (1965). Phytohaemagglutinin induced mitotic stimulation of epithelial cells in organ culture of adult human skin,”
  54. (1986). Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures,”
  55. (2004). Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins,”
  56. (2003). Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgarisinduced, acantholysis in human epidermis,”
  57. (1996). Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study,”
  58. (2004). Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes,”
  59. (2006). Synergistic actions of pemphigus vulgaris IgG, Fasligand and tumor necrosis factor-α during induction of basal cell shrinkage and acantholysis,”
  60. (1998). The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase
  61. (1981). The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis,”
  62. (2003). The plant lectin wheat germ agglutinin inhibits the binding of pemphigus 27 foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents 28 pathomechanisms of pemphigus f oliac e usinvitr oandinvi v o ,
  63. (2009). The ultrastructure of acantholysis in pemphigus vulgaris,”
  64. (2009). X.Mao,E.J.Choi,andA.S.Payne,“Disruptionofdesmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies,”